DFine granted US patent relating to StabiliT Vertebral Augmentation System

DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that the United States Patent & Trademark Office has issued Patent 7,678,116 relating to the StabiliT® Vertebral Augmentation System. Two additional Notices of Allowance have also been issued with patents expected later this year.

“I am pleased with our expanding patent portfolio”

"I am pleased with our expanding patent portfolio," said Kevin Mosher, Chief Executive Officer of DFine, Inc. "DFine has a number of innovative technologies and concepts that will provide the basis for future pipeline products and further enhance the value of our patent portfolio. Combined with our global commercialization efforts, our underlying intellectual property uniquely positions DFine as the technology leader in the treatment of vertebral compression fractures and other vertebral pathologies."

DFine has more than fifty additional patent applications pending in the U.S. Patent & Trademark Office related to the StabiliT® Vertebral Augmentation System used in the treatment of vertebral compression fractures with several new products under development.

Source:

DFine, Inc.,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.